IP Library Granted Patent US 6,864,079
Granted Patent B2
US 6,864,079 · App. 10/116,332 · Granted Mar 8, 2005

Human kinase and polynucleotides encoding the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,864,079
App. No.
10/116,332
Granted
Mar 8, 2005
Kind
B2
Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims (6)

1. An isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1 or the complement thereof.

2. An isolated nucleic acid molecule comprising a nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO:2.

3. A substantially isolated protein having the kinase activity of the protein shown in SEQ ID NO:2, which is encoded by a nucleotide sequence that hybridizes to entire SEQ ID NO:1 under hybridization condition of 0.5 M NaHPO 4 , 7% Sodium dodecyl sulfate (SDS), 1 mM EDTA at 65° C., and wash conditions of 0.1× SSC/0.1% SDS at 68° C.

4. A recombinant expression vector comprising the isolated nucleic acid molecule of claim 2 .

5. The recombinant expression vector of claim 4 , wherein said vector comprises SEQ ID NO: 1.

6. A host cell comprises the recombinant expression vector of claim 4 .

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →